Jaswinder Singh Khera

WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them.

WEP Clinical is a specialist services company founded in 2008 that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. The private company is based in Morrisville, NC, and has offices located in the UK, Switzerland, and Ireland. The company possesses all the necessary licenses allowing them to meet drug access and distribution needs across all regions worldwide. The company also provides pharmacovigilance (PV) services and drug commercialization services to help pharmaceutical companies successfully commercialize products in different countries where the product has yet to be registered. The CEO of the company is Jaswinder Singh Khera.